Posted in

Polymyalgia Rheumatica: Optimizing Care in Older Adults

•Posted inInternal Medicine

Polymyalgia Rheumatica: Optimizing Care in Older Adults

Effective Polymyalgia Rheumatica Management is crucial for patients over 50 years of age. This inflammatory condition primarily targets the shoulders, neck, and hips. Consequently, patients suffer from debilitating pain and morning stiffness. Because the symptoms often mimic other diseases, a systematic approach is necessary for an accurate diagnosis. Physicians must act quickly to provide relief and prevent complications.

Clinical Presentation and Focus on Polymyalgia Rheumatica Management

The hallmark of this disease is sudden-onset bilateral shoulder pain. Additionally, many patients experience significant stiffness in the morning. This stiffness generally lasts more than 45 minutes and limits daily activities. Furthermore, systemic symptoms like low-grade fever or weight loss may occur. Clinicians often observe elevated levels of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). However, doctors must also rule out giant-cell arteritis, which frequently overlaps with this condition.

Standard Treatment Protocols

Glucocorticoids serve as the cornerstone of therapy. Most patients experience rapid symptom relief within days of starting treatment. Specifically, clinicians prescribe an initial dose of 12.5 to 25 mg of prednisone daily. After achieving stability, the physician reduces the dose gradually. Ideally, the tapering process should last approximately 12 months. Since the disease course varies, some individuals require longer therapy to maintain remission.

Addressing Relapses and Sparing Agents

Relapses occur frequently during the tapering phase. Consequently, doctors may introduce steroid-sparing agents to minimize long-term exposure. Methotrexate is a common choice for managing difficult cases. Alternatively, interleukin-6 receptor inhibitors provide an effective biologic option for persistent inflammation. These therapies help reduce the cumulative steroid burden while maintaining patient mobility.

Frequently Asked Questions

Q1: What are the primary symptoms of PMR?

PMR typically causes bilateral shoulder pain, hip or neck pain, and severe morning stiffness in individuals older than 50.

Q2: How long does steroid treatment usually last?

Treatment generally lasts at least 12 months, with a gradual dose reduction to prevent relapses.

Q3: What happens if PMR relapses during tapering?

If symptoms return, doctors may increase the steroid dose or add medications like methotrexate or IL-6 inhibitors.

References

  1. Dejaco C et al. Polymyalgia Rheumatica. N Engl J Med. 2026 Mar 12. doi: 10.1056/NEJMcp2506817. PMID: 41812194.
  2. López-Medina C et al. Traditional and Emerging Strategies for Managing Polymyalgia Rheumatica. J Clin Med. 2024 Oct 29;13(21):6450.
  3. Dey M et al. Systematic literature review to inform the 2025 EULAR recommendations for management of Polymyalgia Rheumatica. ACR Convergence 2025.